Whitehawk Therapeutics Inc(WHWK)

Biotechnology · Morristown, NJ

$3.61-0.09 (-2.43%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T20:04:59.824Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:04:59.824Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -86,056,000
Quote market capitalization: 205,802,490
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 85,234,000

FMP input reference: f69dda8f3330533b5b8c72b5a53e0a0a6fa28851440bc7cc40968d1f378f11ab

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

WHWK EBITDA Yield Metrics

EBITDA YIELD

N/A

WHWK Competitors' EBITDA Yield

WHWK

Whitehawk Therapeutics Inc

Current

Market Cap

$205.80M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PDEX

Pro-Dex, Inc.

vs WHWK

Market Cap

$207.27M

EBITDA Yield

6.62%

TTM Avg

7.98%

3Y Avg

8.26%

5Y Avg

7.82%

ETRA

Electra Therapeutics Inc.

vs WHWK

Market Cap

$208.31M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALEC

Alector, Inc.

vs WHWK

Market Cap

$200.96M

EBITDA Yield

N/A

TTM Avg

6.19%

3Y Avg

6.19%

5Y Avg

6.19%

CGEN

Compugen Ltd.

vs WHWK

Market Cap

$209.91M

EBITDA Yield

N/A

TTM Avg

17.11%

3Y Avg

12.89%

5Y Avg

12.89%

TRDA

Entrada Therapeutics, Inc.

vs WHWK

Market Cap

$210.41M

EBITDA Yield

N/A

TTM Avg

11.62%

3Y Avg

10.33%

5Y Avg

10.33%

LYEL

Lyell Immunopharma, Inc.

vs WHWK

Market Cap

$210.98M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

XGN

Exagen Inc.

vs WHWK

Market Cap

$197.87M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RNAC

Cartesian Therapeutics, Inc.

vs WHWK

Market Cap

$198.33M

EBITDA Yield

N/A

TTM Avg

27.87%

3Y Avg

27.87%

5Y Avg

27.87%

SRZN

Surrozen, Inc.

vs WHWK

Market Cap

$197.18M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Whitehawk Therapeutics Inc (WHWK)	$205.80M	N/A	N/A	N/A	N/A
Pro-Dex, Inc. (PDEX)vs ›	$207.27M	6.62%	7.98%	8.26%	7.82%
Electra Therapeutics Inc. (ETRA)vs ›	$208.31M	N/A	N/A	N/A	N/A
Alector, Inc. (ALEC)vs ›	$200.96M	N/A	6.19%	6.19%	6.19%
Compugen Ltd. (CGEN)vs ›	$209.91M	N/A	17.11%	12.89%	12.89%
Entrada Therapeutics, Inc. (TRDA)vs ›	$210.41M	N/A	11.62%	10.33%	10.33%
Lyell Immunopharma, Inc. (LYEL)vs ›	$210.98M	N/A	N/A	N/A	N/A
Exagen Inc. (XGN)vs ›	$197.87M	N/A	N/A	N/A	N/A
Cartesian Therapeutics, Inc. (RNAC)vs ›	$198.33M	N/A	27.87%	27.87%	27.87%
Surrozen, Inc. (SRZN)vs ›	$197.18M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

WHWK EBITDA Yield Metrics

WHWK Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics